rs145431028

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 2P and 8B. PP3_ModerateBS1BS2

The NM_033409.4(SLC52A3):​c.1371C>G​(p.Phe457Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000671 in 1,610,086 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.00045 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00069 ( 3 hom. )

Consequence

SLC52A3
NM_033409.4 missense

Scores

7
8
3

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:8O:2

Conservation

PhyloP100: 2.78

Publications

11 publications found
Variant links:
Genes affected
SLC52A3 (HGNC:16187): (solute carrier family 52 member 3) This gene encodes a riboflavin transporter protein that is strongly expressed in the intestine and likely plays a role in intestinal absorption of riboflavin. The protein is predicted to have eleven transmembrane domains and a cell surface localization signal in the C-terminus. Mutations at this locus have been associated with Brown-Vialetto-Van Laere syndrome and Fazio-Londe disease. [provided by RefSeq, Mar 2012]
SLC52A3 Gene-Disease associations (from GenCC):
  • Brown-Vialetto-van Laere syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Ambry Genetics, PanelApp Australia, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
  • progressive bulbar palsy
    Inheritance: AR Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.858
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000453 (69/152358) while in subpopulation NFE AF = 0.000882 (60/68032). AF 95% confidence interval is 0.000703. There are 0 homozygotes in GnomAd4. There are 31 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_033409.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC52A3
NM_033409.4
MANE Select
c.1371C>Gp.Phe457Leu
missense
Exon 5 of 5NP_212134.3
SLC52A3
NM_001370085.1
c.1371C>Gp.Phe457Leu
missense
Exon 6 of 6NP_001357014.1Q9NQ40-1
SLC52A3
NM_001370086.1
c.1371C>Gp.Phe457Leu
missense
Exon 6 of 6NP_001357015.1Q9NQ40-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC52A3
ENST00000645534.1
MANE Select
c.1371C>Gp.Phe457Leu
missense
Exon 5 of 5ENSP00000494193.1Q9NQ40-1
SLC52A3
ENST00000217254.11
TSL:5
c.1371C>Gp.Phe457Leu
missense
Exon 6 of 6ENSP00000217254.7Q9NQ40-1
SLC52A3
ENST00000488495.3
TSL:3
c.1371C>Gp.Phe457Leu
missense
Exon 5 of 5ENSP00000494009.1Q9NQ40-1

Frequencies

GnomAD3 genomes
AF:
0.000453
AC:
69
AN:
152240
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000965
Gnomad AMI
AF:
0.00220
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000882
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000374
AC:
89
AN:
237784
AF XY:
0.000353
show subpopulations
Gnomad AFR exome
AF:
0.0000709
Gnomad AMR exome
AF:
0.0000589
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000492
Gnomad NFE exome
AF:
0.000789
Gnomad OTH exome
AF:
0.000171
GnomAD4 exome
AF:
0.000694
AC:
1011
AN:
1457728
Hom.:
3
Cov.:
30
AF XY:
0.000639
AC XY:
463
AN XY:
724978
show subpopulations
African (AFR)
AF:
0.0000898
AC:
3
AN:
33394
American (AMR)
AF:
0.0000449
AC:
2
AN:
44500
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26094
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39468
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85692
European-Finnish (FIN)
AF:
0.0000964
AC:
5
AN:
51892
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5728
European-Non Finnish (NFE)
AF:
0.000872
AC:
969
AN:
1110768
Other (OTH)
AF:
0.000532
AC:
32
AN:
60192
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
61
123
184
246
307
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000453
AC:
69
AN:
152358
Hom.:
0
Cov.:
32
AF XY:
0.000416
AC XY:
31
AN XY:
74496
show subpopulations
African (AFR)
AF:
0.0000962
AC:
4
AN:
41588
American (AMR)
AF:
0.000131
AC:
2
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000882
AC:
60
AN:
68032
Other (OTH)
AF:
0.00
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
5
10
14
19
24
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000672
Hom.:
0
Bravo
AF:
0.000427
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.00104
AC:
4
ESP6500AA
AF:
0.000231
AC:
1
ESP6500EA
AF:
0.000710
AC:
6
ExAC
AF:
0.000290
AC:
35

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
3
-
not provided (3)
-
2
-
Brown-Vialetto-van Laere syndrome 1 (4)
-
1
-
Inborn genetic diseases (1)
-
1
-
not specified (1)
-
1
-
Progressive bulbar palsy of childhood;C0796274:Brown-Vialetto-van Laere syndrome 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.97
BayesDel_addAF
Uncertain
0.095
D
BayesDel_noAF
Pathogenic
0.28
CADD
Benign
22
DANN
Uncertain
1.0
DEOGEN2
Benign
0.28
T
Eigen
Uncertain
0.26
Eigen_PC
Benign
0.074
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Benign
0.77
T
M_CAP
Uncertain
0.16
D
MetaRNN
Pathogenic
0.86
D
MetaSVM
Uncertain
0.20
D
MutationAssessor
Pathogenic
3.3
M
PhyloP100
2.8
PrimateAI
Uncertain
0.70
T
PROVEAN
Pathogenic
-5.5
D
REVEL
Pathogenic
0.78
Sift
Pathogenic
0.0
D
Sift4G
Uncertain
0.012
D
Polyphen
1.0
D
Vest4
0.97
MutPred
0.95
Gain of helix (P = 0.0696)
MVP
0.80
MPC
1.1
ClinPred
0.76
D
GERP RS
1.9
Varity_R
0.86
gMVP
0.82
Mutation Taster
=8/92
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs145431028; hg19: chr20-741709; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.